Calreticulin is a calcium-sequestering protein with a known ability to block VDR signal transduction by interacting with its DNA binding domain [52], which may explain the lack of antiproliferative activity of calcitriol observed in our cultured endothelial cells and in tumor endothelium. The gene discussed is CALR; the disease is neoplasm.